Pediculicide [EPC]

Pediculicide [EPC] was reported 4708 times

These side effects are most commonly reported by patients taking drugs of the Pediculicide [EPC] class:

# Drug class Count
0 DRUG INEFFECTIVE 868
1 HEADACHE 685
2 ASTHENIA 606
3 OFF LABEL USE 545
4 PYREXIA 516
5 PRODUCT USE IN UNAPPROVED INDICATION 490
6 PRURITUS 423
7 DIARRHOEA 328
8 OCULAR HYPERAEMIA 265
9 ERYTHEMA 251
10 COMA 248
11 BACK PAIN 241
12 CONJUNCTIVAL HAEMORRHAGE 237
13 VOMITING 235
14 ARTHRALGIA 229
15 RASH 229
16 FATIGUE 226
17 VERTIGO 219
18 PAIN 210
19 NAUSEA 206
20 GAIT DISTURBANCE 176
21 DYSPNOEA 174
22 CONDITION AGGRAVATED 169
23 ROSACEA 162
24 ENCEPHALOPATHY 147
25 DIZZINESS 139
26 URINARY INCONTINENCE 138
27 MYALGIA 135
28 DEATH 131
29 HYPOTENSION 131
30 SKIN BURNING SENSATION 125
31 STRONGYLOIDIASIS 125
32 DEPRESSED LEVEL OF CONSCIOUSNESS 124
33 ABDOMINAL PAIN 118
34 COVID-19 117
35 WEIGHT DECREASED 113
36 CHILLS 111
37 DRUG INTERACTION 109
38 CONFUSIONAL STATE 105
39 LOSS OF CONSCIOUSNESS 104
40 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 101
41 DRY SKIN 101
42 PNEUMONIA 101
43 PRODUCT USE ISSUE 101
44 COUGH 97
45 MALAISE 95
46 TOXICITY TO VARIOUS AGENTS 95
47 NO ADVERSE EVENT 90
48 PRODUCT DOSE OMISSION ISSUE 88
49 SKIN IRRITATION 86
50 ACUTE KIDNEY INJURY 85
51 INTENTIONAL PRODUCT MISUSE 85
52 SOMNOLENCE 85
53 ALOPECIA 84
54 SKIN EXFOLIATION 83
55 AGITATION 80
56 OVERDOSE 80
57 INSOMNIA 78
58 ABNORMAL BEHAVIOUR 76
59 VISION BLURRED 76
60 URTICARIA 75
61 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 74
62 HYPERSENSITIVITY 73
63 FALL 72
64 DECREASED APPETITE 71
65 INTENTIONAL PRODUCT USE ISSUE 71
66 SEPSIS 70
67 SWELLING FACE 69
68 ANXIETY 68
69 ADVERSE EVENT 67
70 ABDOMINAL PAIN UPPER 66
71 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 66
72 OEDEMA PERIPHERAL 66
73 PARAESTHESIA 66
74 RESPIRATORY FAILURE 66
75 MULTIPLE ORGAN DYSFUNCTION SYNDROME 65
76 URINARY TRACT INFECTION 65
77 HEART RATE INCREASED 63
78 RASH PAPULAR 63
79 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 63
80 PAIN IN EXTREMITY 62
81 SEPTIC SHOCK 62
82 PRODUCT PRESCRIBING ISSUE 61
83 RENAL FAILURE 61
84 WHITE BLOOD CELL COUNT DECREASED 61
85 HEPATIC CYTOLYSIS 60
86 MALARIA 59
87 SEIZURE 58
88 CONSTIPATION 57
89 PAIN OF SKIN 57
90 TREMOR 57
91 APHASIA 56
92 ANAEMIA 55
93 INJECTION SITE PAIN 55
94 HYPERTENSION 54
95 CHEST PAIN 53
96 DEHYDRATION 53
97 FEELING ABNORMAL 52
98 MUSCLE SPASMS 52
99 EOSINOPHILIA 51
100 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 51
101 THROMBOCYTOPENIA 51
102 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 50
103 DRY MOUTH 50
104 PERIPHERAL SWELLING 50
105 DEPRESSION 49
106 DISORIENTATION 49
107 SPEECH DISORDER 49
108 NECK PAIN 48
109 ALANINE AMINOTRANSFERASE INCREASED 47
110 DRUG HYPERSENSITIVITY 47
111 RASH ERYTHEMATOUS 47
112 ABDOMINAL DISTENSION 46
113 FLUSHING 46
114 INFECTION 46
115 VISUAL IMPAIRMENT 46
116 BLOOD PRESSURE INCREASED 45
117 NEUROTOXICITY 45
118 HYPOAESTHESIA 44
119 ILLNESS 44
120 TREATMENT FAILURE 43
121 ACNE 42
122 BURNING SENSATION 42
123 DERMATITIS 42
124 ANOREXIA 41
125 HOT FLUSH 40
126 JOINT SWELLING 40
127 PRODUCT QUALITY ISSUE 40
128 RASH PRURITIC 40
129 BALANCE DISORDER 39
130 DRUG ADMINISTRATION ERROR 39
131 NERVOUS SYSTEM DISORDER 39
132 CHRONIC KIDNEY DISEASE 38
133 DYSPHAGIA 38
134 LOGORRHOEA 38
135 NEUTROPENIA 38
136 PALPITATIONS 38
137 TOXIC EPIDERMAL NECROLYSIS 38
138 DYSSTASIA 37
139 INFLUENZA 37
140 MUSCULOSKELETAL STIFFNESS 37
141 SINUSITIS 37
142 TACHYCARDIA 37
143 WEIGHT INCREASED 37
144 ASTHMA 36
145 BLISTER 36
146 DERMATITIS CONTACT 36
147 MUSCULAR WEAKNESS 36
148 RASH MACULO-PAPULAR 36
149 EXPRESSIVE LANGUAGE DISORDER 35
150 EYE IRRITATION 35
151 EYE PAIN 35
152 GENERAL PHYSICAL HEALTH DETERIORATION 35
153 HEPATOCELLULAR INJURY 35
154 INCORRECT DOSE ADMINISTERED 35
155 EMOTIONAL DISTRESS 34
156 MENTAL STATUS CHANGES 34
157 NASOPHARYNGITIS 34
158 PLATELET COUNT DECREASED 34
159 PSORIASIS 34
160 SELF-MEDICATION 34
161 STEVENS-JOHNSON SYNDROME 34
162 THERAPEUTIC RESPONSE UNEXPECTED 34
163 ALTERED STATE OF CONSCIOUSNESS 33
164 DERMATITIS ATOPIC 33
165 DRUG INTOLERANCE 33
166 FAECAL INCONTINENCE 33
167 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 33
168 ABDOMINAL DISCOMFORT 32
169 ACARODERMATITIS 32
170 CARDIAC FAILURE 31
171 SKIN DISORDER 31
172 THERAPY NON-RESPONDER 31
173 ASPARTATE AMINOTRANSFERASE INCREASED 30
174 ATRIAL FIBRILLATION 30
175 DERMATITIS ALLERGIC 30
176 DISCOMFORT 30
177 EXPIRED PRODUCT ADMINISTERED 30
178 FEELING HOT 30
179 LIP SWELLING 30
180 SWOLLEN TONGUE 30
181 SYNCOPE 30
182 ECZEMA 29
183 EYELID OEDEMA 29
184 HAEMATOCHEZIA 29
185 OEDEMA 29
186 OROPHARYNGEAL PAIN 29
187 LIVER DISORDER 28
188 MIXED LIVER INJURY 28
189 RASH MACULAR 28
190 BLOOD PRESSURE DECREASED 27
191 DYSPEPSIA 27
192 EYE SWELLING 27
193 GASTROINTESTINAL DISORDER 27
194 HYPONATRAEMIA 27
195 INFLAMMATION 27
196 METABOLIC ACIDOSIS 27
197 SKIN DISCOLOURATION 27
198 ACUTE RESPIRATORY DISTRESS SYNDROME 26
199 APPLICATION SITE ERYTHEMA 26
200 BLOOD CREATININE INCREASED 26
201 CHEST DISCOMFORT 26
202 CHROMATURIA 26
203 EAR INFECTION 26
204 GASTROOESOPHAGEAL REFLUX DISEASE 26
205 HEPATITIS 26
206 HYPOXIA 26
207 INCORRECT DRUG ADMINISTRATION DURATION 26
208 INTENTIONAL OVERDOSE 26
209 LUNG DISORDER 26
210 RHINOCEREBRAL MUCORMYCOSIS 26
211 CANDIDA INFECTION 25
212 HALLUCINATION 25
213 LICE INFESTATION 25
214 MEMORY IMPAIRMENT 25
215 METHAEMOGLOBINAEMIA 25
216 PANCYTOPENIA 25
217 RED BLOOD CELL COUNT DECREASED 25
218 SWELLING 25
219 URINARY RETENTION 25
220 ABNORMAL FAECES 24
221 BLOOD PRESSURE ABNORMAL 24
222 DECUBITUS ULCER 24
223 DISSEMINATED STRONGYLOIDIASIS 24
224 DYSPHONIA 24
225 HAEMOGLOBIN DECREASED 24
226 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 24
227 PRODUCTIVE COUGH 24
228 APPLICATION SITE PAIN 23
229 GASTROINTESTINAL HAEMORRHAGE 23
230 HEPATIC FAILURE 23
231 HYPERHIDROSIS 23
232 INJECTION SITE ERYTHEMA 23
233 MUSCULOSKELETAL DISCOMFORT 23
234 ORAL DISCOMFORT 23
235 PERIPHERAL COLDNESS 23
236 RENAL IMPAIRMENT 23
237 UPPER RESPIRATORY TRACT INFECTION 23
238 ACCIDENTAL EXPOSURE TO PRODUCT 22
239 ACUTE RESPIRATORY FAILURE 22
240 ADVERSE DRUG REACTION 22
241 AGRANULOCYTOSIS 22
242 ASCITES 22
243 CARDIAC ARREST 22
244 CELLULITIS 22
245 DRUG-INDUCED LIVER INJURY 22
246 GASTROINTESTINAL MOTILITY DISORDER 22
247 IRRITABILITY 22
248 MENTAL DISORDER 22
249 SLEEP DISORDER 22
250 STUPOR 22
251 SUICIDAL IDEATION 22
252 AMNESIA 21
253 BLINDNESS 21
254 BRADYCARDIA 21
255 CEREBROVASCULAR ACCIDENT 21
256 CONTUSION 21
257 DISEASE PROGRESSION 21
258 OXYGEN SATURATION DECREASED 21
259 PRODUCT AVAILABILITY ISSUE 21
260 RHINORRHOEA 21
261 SOMATIC DELUSION 21
262 ABASIA 20
263 ARTHRITIS 20
264 BLOOD GLUCOSE INCREASED 20
265 CARDIO-RESPIRATORY ARREST 20
266 DELIRIUM 20
267 DRY EYE 20
268 EXPOSURE DURING PREGNANCY 20
269 FEELING COLD 20
270 IMPAIRED QUALITY OF LIFE 20
271 MATERNAL EXPOSURE DURING PREGNANCY 20
272 NEUROPATHY PERIPHERAL 20
273 SKIN LESION 20
274 TINNITUS 20
275 TOXIC ENCEPHALOPATHY 20
276 URINE ODOUR ABNORMAL 20
277 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 19
278 BLOOD ALKALINE PHOSPHATASE INCREASED 19
279 BRONCHOPULMONARY ASPERGILLOSIS 19
280 CHOLESTASIS 19
281 DISEASE RECURRENCE 19
282 EPISTAXIS 19
283 EYE PRURITUS 19
284 HEPATIC ENZYME INCREASED 19
285 HYPOGLYCAEMIA 19
286 JAUNDICE 19
287 PRURITUS GENERALISED 19
288 THERAPEUTIC RESPONSE DECREASED 19
289 COLITIS 18
290 CONJUNCTIVITIS 18
291 COVID-19 PNEUMONIA 18
292 DYSARTHRIA 18
293 FLATULENCE 18
294 FORMICATION 18
295 HEPATIC FUNCTION ABNORMAL 18
296 INFECTION PARASITIC 18
297 INTENTIONAL DOSE OMISSION 18
298 LYMPHADENOPATHY 18
299 MIGRAINE 18
300 NUCHAL RIGIDITY 18
301 PULMONARY EMBOLISM 18
302 RESPIRATORY DISTRESS 18
303 STRESS 18
304 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 18
305 APPLICATION SITE PRURITUS 17
306 ELECTROCARDIOGRAM QT PROLONGED 17
307 FACE OEDEMA 17
308 FUNGAL INFECTION 17
309 LACRIMATION INCREASED 17
310 MOBILITY DECREASED 17
311 MYELOSUPPRESSION 17
312 PUSTULE 17
313 SCAB 17
314 THERAPY INTERRUPTED 17
315 UNDERDOSE 17
316 ANGIOEDEMA 16
317 CONVULSION 16
318 CYSTITIS 16
319 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 16
320 DYSGEUSIA 16
321 ELECTROLYTE IMBALANCE 16
322 HEPATOTOXICITY 16
323 LETHARGY 16
324 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 16
325 MULTI-ORGAN FAILURE 16
326 OSTEOPOROSIS 16
327 PERIARTHRITIS 16
328 PNEUMONIA ASPIRATION 16
329 PSORIATIC ARTHROPATHY 16
330 RESPIRATORY DISORDER 16
331 SURGERY 16
332 THROMBOSIS 16
333 UNRESPONSIVE TO STIMULI 16
334 ACCIDENTAL OVERDOSE 15
335 AGGRESSION 15
336 BLOOD POTASSIUM DECREASED 15
337 BONE PAIN 15
338 CONJUNCTIVAL HYPERAEMIA 15
339 DIABETES MELLITUS 15
340 FOETAL EXPOSURE DURING PREGNANCY 15
341 HERPES ZOSTER 15
342 HYPERCALCAEMIA 15
343 POOR QUALITY PRODUCT ADMINISTERED 15
344 SHOCK HAEMORRHAGIC 15
345 SKIN REACTION 15
346 WHEEZING 15
347 WHITE BLOOD CELL COUNT INCREASED 15
348 ABDOMINAL PAIN LOWER 14
349 ANAPHYLACTIC REACTION 14
350 ANHEDONIA 14
351 ARRHYTHMIA 14
352 BACTERAEMIA 14
353 BLOOD BILIRUBIN INCREASED 14
354 BRONCHITIS 14
355 DRUG DOSE OMISSION 14
356 EYE DISORDER 14
357 GAIT INABILITY 14
358 GASTRITIS EROSIVE 14
359 GENERALISED OEDEMA 14
360 HAEMORRHAGE 14
361 HOSPITALISATION 14
362 INCONTINENCE 14
363 MALIGNANT NEOPLASM PROGRESSION 14
364 MYOCARDIAL INFARCTION 14
365 PEMPHIGOID 14
366 PRODUCT ODOUR ABNORMAL 14
367 ATAXIA 13
368 CARDIAC DISORDER 13
369 CHEILITIS 13
370 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 13
371 DERMATITIS BULLOUS 13
372 DISSEMINATED INTRAVASCULAR COAGULATION 13
373 DRUG ERUPTION 13
374 DRUG RESISTANCE 13
375 EATING DISORDER 13
376 EOSINOPHIL COUNT INCREASED 13
377 ERUCTATION 13
378 ESCHERICHIA INFECTION 13
379 GASTRITIS 13
380 HEAD DISCOMFORT 13
381 HYPERAMMONAEMIA 13
382 ILEUS 13
383 INFLUENZA LIKE ILLNESS 13
384 INTENTIONAL UNDERDOSE 13
385 NASAL CONGESTION 13
386 PALLOR 13
387 PRODUCT SUBSTITUTION ISSUE 13
388 PSYCHOMOTOR HYPERACTIVITY 13
389 RASH PUSTULAR 13
390 RENAL FAILURE ACUTE 13
391 SECRETION DISCHARGE 13
392 STAPHYLOCOCCAL INFECTION 13
393 TREATMENT NONCOMPLIANCE 13
394 CYTOMEGALOVIRUS INFECTION 12
395 DIPLOPIA 12
396 DRUG ABUSE 12
397 FEBRILE NEUTROPENIA 12
398 HAEMATURIA 12
399 MEDICATION ERROR 12
400 NEPHROLITHIASIS 12
401 ORTHOSTATIC HYPOTENSION 12
402 PETECHIAE 12
403 PLEURAL EFFUSION 12
404 POISONING DELIBERATE 12
405 PRESCRIBED OVERDOSE 12
406 PRODUCT DOSE OMISSION IN ERROR 12
407 PRODUCT PRESCRIBING ERROR 12
408 SHOCK 12
409 SKIN HYPERPIGMENTATION 12
410 SKIN SWELLING 12
411 SKIN ULCER 12
412 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 12
413 TACHYPNOEA 12
414 TRANSIENT ISCHAEMIC ATTACK 12
415 UNEVALUABLE EVENT 12
416 VASCULITIS 12
417 APATHY 11
418 BODY TEMPERATURE INCREASED 11
419 CATARACT 11
420 CRYING 11
421 ENDOCRINE OPHTHALMOPATHY 11
422 ENTEROCOCCAL INFECTION 11
423 HAEMATEMESIS 11
424 HAEMOPTYSIS 11
425 HEMIPLEGIA 11
426 HYPERGLYCAEMIA 11
427 HYPERKALAEMIA 11
428 HYPERSOMNIA 11
429 ILL-DEFINED DISORDER 11
430 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11
431 INJECTION SITE BRUISING 11
432 INJECTION SITE SWELLING 11
433 JOINT STIFFNESS 11
434 LACTIC ACIDOSIS 11
435 LOWER RESPIRATORY TRACT INFECTION 11
436 MUSCULOSKELETAL CHEST PAIN 11
437 MYDRIASIS 11
438 PARESIS 11
439 PHOTOPHOBIA 11
440 PRODUCT PACKAGING QUANTITY ISSUE 11
441 PRODUCT PREPARATION ERROR 11
442 RALES 11
443 RHEUMATOID ARTHRITIS 11
444 SKIN HAEMORRHAGE 11
445 SUICIDE ATTEMPT 11
446 THROAT IRRITATION 11
447 VISUAL ACUITY REDUCED 11
448 ANAPHYLACTIC SHOCK 10
449 APLASIA PURE RED CELL 10
450 BLOOD CHOLESTEROL INCREASED 10
451 BRAIN OEDEMA 10
452 DEEP VEIN THROMBOSIS 10
453 EXTRA DOSE ADMINISTERED 10
454 EYE DISCHARGE 10
455 GRAVES^ DISEASE 10
456 HEPATOMEGALY 10
457 HYPOKALAEMIA 10
458 IMMUNE SYSTEM DISORDER 10
459 INCORRECT ROUTE OF DRUG ADMINISTRATION 10
460 INFUSION RELATED REACTION 10
461 INFUSION SITE PAIN 10
462 MONOPARESIS 10
463 MULTIPLE USE OF SINGLE-USE PRODUCT 10
464 OCULAR DISCOMFORT 10
465 ORAL HERPES 10
466 OSTEOPENIA 10
467 PANCREATITIS 10
468 PNEUMONITIS 10
469 PRODUCT PHYSICAL CONSISTENCY ISSUE 10
470 PRODUCT USE COMPLAINT 10
471 SCAR 10
472 SKIN WARM 10
473 SMALL INTESTINAL OBSTRUCTION 10
474 STOMATITIS 10
475 THERAPEUTIC RESPONSE SHORTENED 10
476 APPLICATION SITE IRRITATION 9
477 APPLICATION SITE SWELLING 9
478 BACTERIAL INFECTION 9
479 BLOOD MAGNESIUM DECREASED 9
480 BLOOD TRIGLYCERIDES INCREASED 9
481 BLOOD UREA INCREASED 9
482 BRAIN FOG 9
483 C-REACTIVE PROTEIN INCREASED 9
484 CHOLELITHIASIS 9
485 CLOSTRIDIUM DIFFICILE COLITIS 9
486 CYTOKINE RELEASE SYNDROME 9
487 DIFFICULTY IN WALKING 9
488 DRUG EFFECT DECREASED 9
489 DYSPNOEA EXERTIONAL 9
490 ENCEPHALITIS 9
491 ERYTHEMA MULTIFORME 9
492 FAECES DISCOLOURED 9
493 FILARIASIS 9
494 HAIR DISORDER 9
495 HEREDITARY ANGIOEDEMA 9
496 HYPERBILIRUBINAEMIA 9
497 HYPERNATRAEMIA 9
498 HYPOTHYROIDISM 9
499 INCOHERENT 9
500 INJECTION SITE PRURITUS 9
501 INSURANCE ISSUE 9
502 INTESTINAL OBSTRUCTION 9
503 INTRACRANIAL PRESSURE INCREASED 9
504 KLEBSIELLA INFECTION 9
505 LEUKOPENIA 9
506 LIMB INJURY 9
507 LIVER FUNCTION TEST INCREASED 9
508 LOCALISED OEDEMA 9
509 MALNUTRITION 9
510 MAZZOTTI REACTION 9
511 MELAENA 9
512 MENINGITIS 9
513 MOUTH ULCERATION 9
514 MUSCLE TWITCHING 9
515 NEMATODIASIS 9
516 NEOPLASM MALIGNANT 9
517 NEUTROPHIL COUNT DECREASED 9
518 NIGHT SWEATS 9
519 PAIN IN JAW 9
520 PARALYSIS 9
521 PHOTOSENSITIVITY REACTION 9
522 PLASMA CELL MYELOMA 9
523 PURPURA 9
524 RECTAL HAEMORRHAGE 9
525 SARS-COV-2 TEST POSITIVE 9
526 SCRATCH 9
527 SEASONAL ALLERGY 9
528 SKIN TIGHTNESS 9
529 SUDDEN DEATH 9
530 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 9
531 TRANSAMINASES INCREASED 9
532 ACUTE HEPATIC FAILURE 8
533 APPLICATION SITE RASH 8
534 ARTHROPOD BITE 8
535 BLOOD PHOSPHORUS DECREASED 8
536 CARDIAC MURMUR 8
537 CEREBRAL INFARCTION 8
538 CHORIORETINOPATHY 8
539 CIRCULATORY COLLAPSE 8
540 COAGULOPATHY 8
541 COGNITIVE DISORDER 8
542 COMA SCALE ABNORMAL 8
543 CROHN^S DISEASE 8
544 CYTOLYTIC HEPATITIS 8
545 DERMATITIS EXFOLIATIVE 8
546 DISABILITY 8
547 DISTURBANCE IN ATTENTION 8
548 DRUG EXPOSURE DURING PREGNANCY 8
549 END STAGE RENAL DISEASE 8
550 FAECES HARD 8
551 FEEDING DISORDER 8
552 FREQUENT BOWEL MOVEMENTS 8
553 FUNGAEMIA 8
554 HALLUCINATION, VISUAL 8
555 HEAD INJURY 8
556 HEPATIC CIRRHOSIS 8
557 HERPES SIMPLEX 8
558 HYPERSENSITIVITY VASCULITIS 8
559 HYPOACUSIS 8
560 INFUSION SITE ERYTHEMA 8
561 INJECTION SITE MASS 8
562 INJURY 8
563 INTERSTITIAL LUNG DISEASE 8
564 LEUKOCYTOSIS 8
565 MOVEMENT DISORDER 8
566 ORAL CANDIDIASIS 8
567 OSTEOARTHRITIS 8
568 PAPULE 8
569 PERIORBITAL SWELLING 8
570 PHARYNGEAL OEDEMA 8
571 POLYARTHRITIS 8
572 PRESYNCOPE 8
573 PRODUCT ADMINISTRATION ERROR 8
574 PRODUCT STORAGE ERROR 8
575 PULMONARY OEDEMA 8
576 PULSE ABNORMAL 8
577 RESPIRATORY ARREST 8
578 RESPIRATORY TRACT INFECTION 8
579 RHABDOMYOLYSIS 8
580 SINUSITIS FUNGAL 8
581 THERAPY CESSATION 8
582 THROAT TIGHTNESS 8
583 VIRAL INFECTION 8
584 VITREOUS FLOATERS 8
585 ABORTION SPONTANEOUS 7
586 ACIDOSIS 7
587 APPLICATION SITE BURN 7
588 APPLICATION SITE DRYNESS 7
589 APPLICATION SITE EXFOLIATION 7
590 AUTOIMMUNE HEPATITIS 7
591 BLOOD CREATINE PHOSPHOKINASE INCREASED 7
592 BLOOD SODIUM DECREASED 7
593 BONE DENSITY DECREASED 7
594 BRAIN DEATH 7
595 CARBOHYDRATE ANTIGEN 125 INCREASED 7
596 CARDIOVASCULAR DISORDER 7
597 CEREBRAL DISORDER 7
598 CEREBRAL HAEMORRHAGE 7
599 CYTOMEGALOVIRUS INFECTION REACTIVATION 7
600 CYTOPENIA 7
601 DANDRUFF 7
602 DEFAECATION URGENCY 7
603 DIABETES INSIPIDUS 7
604 DIVERTICULITIS 7
605 DRY THROAT 7
606 DUODENAL ULCER 7
607 EAR PAIN 7
608 ECONOMIC PROBLEM 7
609 ERECTILE DYSFUNCTION 7
610 ESCHERICHIA BACTERAEMIA 7
611 HEART RATE DECREASED 7
612 HYPERTHERMIA 7
613 HYPOCALCAEMIA 7
614 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7
615 INCORRECT PRODUCT ADMINISTRATION DURATION 7
616 INFESTATION 7
617 INJECTION SITE IRRITATION 7
618 JOINT RANGE OF MOTION DECREASED 7
619 KLEBSIELLA TEST POSITIVE 7
620 LICHENOID KERATOSIS 7
621 LIVER FUNCTION TEST ABNORMAL 7
622 LYMPHOPENIA 7
623 MOOD ALTERED 7
624 MUCOSAL INFLAMMATION 7
625 MULTIPLE SCLEROSIS 7
626 MULTIPLE SCLEROSIS RELAPSE 7
627 MUTISM 7
628 NYSTAGMUS 7
629 ORAL PAIN 7
630 PANCREATITIS ACUTE 7
631 PERIORBITAL OEDEMA 7
632 PHOTOPSIA 7
633 POISONING 7
634 PRODUCT DOSE OMISSION 7
635 PSEUDOMONAL SEPSIS 7
636 RENAL DISORDER 7
637 SEBORRHOEA 7
638 SKIN DISCOMFORT 7
639 SKIN FISSURES 7
640 THERAPEUTIC PRODUCT EFFECT DECREASED 7
641 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 7
642 TOOTH ABSCESS 7
643 TORSADE DE POINTES 7
644 ULCER 7
645 VASCULAR PURPURA 7
646 VISCERAL LARVA MIGRANS 7
647 VITAMIN D DEFICIENCY 7
648 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7
649 ANGER 6
650 ANURIA 6
651 APHONIA 6
652 APPLICATION SITE INFLAMMATION 6
653 ARTHROPATHY 6
654 ATELECTASIS 6
655 BACTERIAL SEPSIS 6
656 BLOOD DISORDER 6
657 BLOOD SMEAR TEST ABNORMAL 6
658 CARDIAC FAILURE CONGESTIVE 6
659 COLITIS ULCERATIVE 6
660 CORONARY ARTERY DISEASE 6
661 CYST 6
662 DEAFNESS NEUROSENSORY 6
663 DERMATITIS ACNEIFORM 6
664 DIARRHOEA HAEMORRHAGIC 6
665 DRUG DEPENDENCE 6
666 DRUG LEVEL DECREASED 6
667 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 6
668 EYE INFECTION 6
669 FACIAL PAIN 6
670 FEAR 6
671 FLUID RETENTION 6
672 FOOT FRACTURE 6
673 GASTRIC DISORDER 6
674 GASTROENTERITIS 6
675 GLOMERULAR FILTRATION RATE DECREASED 6
676 GLOMERULONEPHRITIS MEMBRANOUS 6
677 HAEMATOCRIT DECREASED 6
678 HAEMATOMA 6
679 HEART RATE ABNORMAL 6
680 HELMINTHIC INFECTION 6
681 HEPATIC STEATOSIS 6
682 HICCUPS 6
683 HUNGER 6
684 HYPERREFLEXIA 6
685 HYPOPHAGIA 6
686 HYPOPHOSPHATAEMIA 6
687 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 6
688 INFUSION SITE SWELLING 6
689 INJECTION SITE REACTION 6
690 INTERNATIONAL NORMALISED RATIO INCREASED 6
691 KIDNEY INFECTION 6
692 LIMB DISCOMFORT 6
693 LUNG INFILTRATION 6
694 LYME DISEASE 6
695 LYMPHANGITIS 6
696 MUCORMYCOSIS 6
697 MUSCLE FATIGUE 6
698 MYOCLONUS 6
699 NAIL DISORDER 6
700 NODULE 6
701 OLIGURIA 6
702 ONYCHOMYCOSIS 6
703 ORAL DISORDER 6
704 ORAL INFECTION 6
705 PARAPARESIS 6
706 PHARYNGEAL SWELLING 6
707 PNEUMONIA KLEBSIELLA 6
708 PRODUCT ADMINISTRATION INTERRUPTED 6
709 PRODUCT DISTRIBUTION ISSUE 6
710 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6
711 PSEUDOMONAS INFECTION 6
712 PSYCHOTIC DISORDER 6
713 PULMONARY CONGESTION 6
714 RASH GENERALISED 6
715 ROAD TRAFFIC ACCIDENT 6
716 SALIVARY HYPERSECRETION 6
717 SCABIES 6
718 SEDATION 6
719 SINUS DISORDER 6
720 SKIN LACERATION 6
721 SKIN MASS 6
722 SLEEP APNOEA SYNDROME 6
723 SLUGGISHNESS 6
724 STAPHYLOCOCCAL BACTERAEMIA 6
725 SWELLING OF EYELID 6
726 TEMPERATURE INTOLERANCE 6
727 THERAPY PARTIAL RESPONDER 6
728 TOOTH DISORDER 6
729 TOOTHACHE 6
730 TYPE 2 DIABETES MELLITUS 6
731 UROSEPSIS 6
732 VENTRICULAR ARRHYTHMIA 6
733 ABNORMAL SENSATION IN EYE 5
734 ADVERSE REACTION 5
735 APLASTIC ANAEMIA 5
736 ATRIAL FLUTTER 5
737 BASAL CELL CARCINOMA 5
738 BLOOD IMMUNOGLOBULIN E INCREASED 5
739 BLOOD LACTATE DEHYDROGENASE INCREASED 5
740 BODY TEMPERATURE ABNORMAL 5
741 BODY TEMPERATURE DECREASED 5
742 BRONCHOSPASM 5
743 CENTRAL NERVOUS SYSTEM INFECTION 5
744 CENTRAL NERVOUS SYSTEM LESION 5
745 CEREBELLAR STROKE 5
746 CERVICAL DYSPLASIA 5
747 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5
748 CONTRAINDICATED PRODUCT ADMINISTERED 5
749 CREPITATIONS 5
750 DECREASED ACTIVITY 5
751 DRUG EFFECT INCOMPLETE 5
752 DRUG EFFECT LESS THAN EXPECTED 5
753 DRUG PRESCRIBING ERROR 5
754 DYSURIA 5
755 EAR DISCOMFORT 5
756 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 5
757 ERYTHEMA OF EYELID 5
758 EXTRASYSTOLES 5
759 FEELING DRUNK 5
760 FIBROMYALGIA 5
761 FOOD ALLERGY 5
762 GASPING SYNDROME 5
763 GASTROENTERITIS VIRAL 5
764 HAEMORRHOIDS 5
765 HEPATITIS ACUTE 5
766 HIATUS HERNIA 5
767 HOOKWORM INFECTION 5
768 HYPEREOSINOPHILIC SYNDROME 5
769 HYPERPARATHYROIDISM SECONDARY 5
770 HYPERVENTILATION 5
771 HYPOKINESIA 5
772 INCREASED TENDENCY TO BRUISE 5
773 INFUSION SITE EXTRAVASATION 5
774 INTENTION TREMOR 5
775 IRRITABLE BOWEL SYNDROME 5
776 LIQUID PRODUCT PHYSICAL ISSUE 5
777 LOCALISED INFECTION 5
778 MACULAR DEGENERATION 5
779 MENTAL IMPAIRMENT 5
780 METASTASES TO BONE 5
781 MUSCLE ATROPHY 5
782 MUSCLE TIGHTNESS 5
783 MUSCULOSKELETAL PAIN 5
784 MYOCARDITIS 5
785 NERVOUSNESS 5
786 NEURALGIA 5
787 ONYCHOCLASIS 5
788 OROPHARYNGEAL DISCOMFORT 5
789 PARAESTHESIA ORAL 5
790 PATHOGEN RESISTANCE 5
791 PERICARDIAL EFFUSION 5
792 PHYSICAL DISABILITY 5
793 PNEUMONIA BACTERIAL 5
794 POLLAKIURIA 5
795 POOR VENOUS ACCESS 5
796 POST PROCEDURAL COMPLICATION 5
797 PRE-EXISTING CONDITION IMPROVED 5
798 PRODUCT PHYSICAL ISSUE 5
799 PULMONARY ALVEOLAR HAEMORRHAGE 5
800 REBOUND ACID HYPERSECRETION 5
801 REBOUND EFFECT 5
802 RED BLOOD CELL COUNT INCREASED 5
803 RENAL INJURY 5
804 RENAL PAIN 5
805 RESPIRATORY TRACT CONGESTION 5
806 RESTLESSNESS 5
807 SCHISTOSOMIASIS 5
808 SCROTAL SWELLING 5
809 SENSITIVE SKIN 5
810 SKIN CANCER 5
811 SKIN HYPOPIGMENTATION 5
812 SQUAMOUS CELL CARCINOMA OF SKIN 5
813 SUPERFICIAL VEIN THROMBOSIS 5
814 SUPERINFECTION 5
815 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 5
816 TACHYARRHYTHMIA 5
817 TASTE DISORDER 5
818 TEMPOROMANDIBULAR JOINT SYNDROME 5
819 TENDONITIS 5
820 THINKING ABNORMAL 5
821 TONGUE HAEMATOMA 5
822 TOOTH INFECTION 5
823 TOOTH LOSS 5
824 TUMOUR LYSIS SYNDROME 5
825 UNDERWEIGHT 5
826 UPPER LIMB FRACTURE 5
827 URINARY HESITATION 5
828 VIROLOGIC FAILURE 5
829 WEIGHT FLUCTUATION 5
830 WOUND 5
831 WOUND INFECTION 5
832 ABNORMAL DREAMS 4
833 ABORTION INDUCED 4
834 ACNE CYSTIC 4
835 ACTIVITIES OF DAILY LIVING IMPAIRED 4
836 ACUTE MYOCARDIAL INFARCTION 4
837 ADRENAL INSUFFICIENCY 4
838 AFFECT LABILITY 4
839 AGEUSIA 4
840 ANAL INCONTINENCE 4
841 ANAL SPHINCTER ATONY 4
842 ANOSMIA 4
843 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 4
844 APNOEA 4
845 APPLICATION SITE DISCOLOURATION 4
846 APPLICATION SITE REACTION 4
847 ASPERGILLUS INFECTION 4
848 BEDRIDDEN 4
849 BENIGN PROSTATIC HYPERPLASIA 4
850 BLINDNESS TRANSIENT 4
851 BLINDNESS UNILATERAL 4
852 BLOOD CALCIUM DECREASED 4
853 BLOOD TEST ABNORMAL 4
854 BODY HEIGHT DECREASED 4
855 BONE DISORDER 4
856 BRAIN INJURY 4
857 BRONCHIAL WALL THICKENING 4
858 BRONCHIECTASIS 4
859 BRONCHIOLITIS 4
860 BURSITIS 4
861 CEREBELLAR SYNDROME 4
862 CHOKING 4
863 CHOLECYSTECTOMY 4
864 COLON CANCER 4
865 CONGENITAL CARDIOVASCULAR ANOMALY 4
866 CONGENITAL MUSCLE ABSENCE 4
867 CORTISOL INCREASED 4
868 DEMENTIA 4
869 DEVICE ISSUE 4
870 DEVICE MALFUNCTION 4
871 DEVICE RELATED INFECTION 4
872 DIABETIC KETOACIDOSIS 4
873 DRUG DEPENDENCE, ANTEPARTUM 4
874 DUODENITIS 4
875 DYSKINESIA 4
876 ENTERITIS 4
877 EPILEPSY 4
878 ESCHERICHIA SEPSIS 4
879 EXOSTOSIS 4
880 EXPOSURE VIA SKIN CONTACT 4
881 EYELID MARGIN CRUSTING 4
882 EYELID PTOSIS 4
883 FACIAL PARALYSIS 4
884 FIBRIN D DIMER INCREASED 4
885 FOLLICULITIS 4
886 FOOD INTOLERANCE 4
887 FOREIGN BODY SENSATION IN EYES 4
888 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4
889 GASTROINTESTINAL INFECTION 4
890 GASTROINTESTINAL PAIN 4
891 GENERALISED ERYTHEMA 4
892 GINGIVAL BLEEDING 4
893 GLASGOW COMA SCALE ABNORMAL 4
894 GLOSSODYNIA 4
895 GLYCOSYLATED HAEMOGLOBIN INCREASED 4
896 GOUT 4
897 HAEMODYNAMIC INSTABILITY 4
898 HEART RATE IRREGULAR 4
899 HEMIPARESIS 4
900 HEPATIC NECROSIS 4
901 HEPATIC PAIN 4
902 HEPATITIS CHOLESTATIC 4
903 HEPATORENAL FAILURE 4
904 HERPES SIMPLEX HEPATITIS 4
905 HORDEOLUM 4
906 HORMONE LEVEL ABNORMAL 4
907 HYDROCEPHALUS 4
908 IMMOBILE 4
909 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 4
910 IMMUNODEFICIENCY 4
911 IMPAIRED HEALING 4
912 INCREASED APPETITE 4
913 INFLAMMATORY MARKER INCREASED 4
914 INJECTION SITE HAEMORRHAGE 4
915 INJECTION SITE RASH 4
916 INJECTION SITE URTICARIA 4
917 INTERVERTEBRAL DISC DEGENERATION 4
918 INTRA-ABDOMINAL HAEMATOMA 4
919 KNEE ARTHROPLASTY 4
920 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4
921 LABORATORY TEST ABNORMAL 4
922 LARGE INTESTINE PERFORATION 4
923 LIGAMENT SPRAIN 4
924 LIVEDO RETICULARIS 4
925 LOCAL SWELLING 4
926 LUNG OPACITY 4
927 MARASMUS 4
928 MASS 4
929 METABOLIC ENCEPHALOPATHY 4
930 MUCOUS STOOLS 4
931 MULTIPLE ALLERGIES 4
932 MUSCLE RIGIDITY 4
933 MUSCULOSKELETAL DISORDER 4
934 NEPHROGENIC ANAEMIA 4
935 NEUROLOGICAL SYMPTOM 4
936 NEUROPSYCHOLOGICAL SYMPTOMS 4
937 NEUTROPHIL COUNT INCREASED 4
938 NIGHTMARE 4
939 OBESITY 4
940 OCULAR ICTERUS 4
941 OESOPHAGITIS 4
942 OSMOTIC DEMYELINATION SYNDROME 4
943 OSTEONECROSIS OF JAW 4
944 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4
945 PANIC ATTACK 4
946 PARADOXICAL DRUG REACTION 4
947 PARANASAL SINUS DISCOMFORT 4
948 PARANOIA 4
949 PARTIAL SEIZURES 4
950 PERIORAL DERMATITIS 4
951 PERIPHERAL VENOUS DISEASE 4
952 PHARYNGITIS 4
953 PHARYNGITIS STREPTOCOCCAL 4
954 POOR QUALITY SLEEP 4
955 PREMATURE DELIVERY 4
956 PROCEDURAL PAIN 4
957 PROCTALGIA 4
958 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 4
959 PROSTATE CANCER 4
960 PROTEINURIA 4
961 PRURITUS ALLERGIC 4
962 PULMONARY MASS 4
963 PULSELESS ELECTRICAL ACTIVITY 4
964 RESPIRATION ABNORMAL 4
965 RETCHING 4
966 RHEUMATOID FACTOR INCREASED 4
967 RHINITIS 4
968 SCOLIOSIS 4
969 SENSORY DISTURBANCE 4
970 SENSORY LOSS 4
971 SINUS CONGESTION 4
972 SINUS TACHYCARDIA 4
973 SKIN WEEPING 4
974 SKIN WOUND 4
975 SNEEZING 4
976 SPINAL PAIN 4
977 SPIROMETRY ABNORMAL 4
978 STATUS EPILEPTICUS 4
979 SUBSTANCE USE DISORDER 4
980 SUPERINFECTION BACTERIAL 4
981 SUPRAPUBIC PAIN 4
982 SYNOVIAL CYST 4
983 TENDERNESS 4
984 TESTICULAR PAIN 4
985 THERAPEUTIC PRODUCT EFFECT DELAYED 4
986 THIRST 4
987 THYROID FUNCTION TEST ABNORMAL 4
988 TOXIC SKIN ERUPTION 4
989 UPPER-AIRWAY COUGH SYNDROME 4
990 VENTRICULAR EXTRASYSTOLES 4
991 VENTRICULAR FIBRILLATION 4
992 VIRAL MUTATION IDENTIFIED 4
993 VITAMIN B12 DEFICIENCY 4
994 VITAMIN D DECREASED 4
995 WITHDRAWAL SYNDROME 4
996 WRONG PATIENT RECEIVED PRODUCT 4
997 WRONG PRODUCT ADMINISTERED 4
998 ABSCESS 3
999 ABSCESS LIMB 3